Safety and efficacy of intracapsular tranilast microspheres in experimental posterior capsule opacification
Authors:
- Man WangMWMan Wang
- Jin-Jun ZhangJZJin-Jun Zhang
- Timothy L. JacksonTJTimothy L. Jackson
- Xinghuai SunXSXinghuai Sun
- Wei WuWei Wu
- John MarshallJMJohn Marshall
- 1 December 2007
- journal article
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 33 (12) , 2122-2128
Abstract
To evaluate the safety and efficacy of a sustained-release agent designed to reduce posterior capsule opacification (PCO). Department of Ophthalmology, EENT Hospital, Fudan University, Shanghai, Peoples Republic of China. Free tranilast (TFree) was incorporated into polylactic acid microspheres and then tested using a rabbit model of PCO. Twenty-nine rabbits were randomized into 5 groups treated with balanced saline solution (BSS control); TFree; or 0.5, 1.0, or 2.0 mg tranilast microspheres (TMicro). Standard phacoemulsification cataract surgery, including manual aspiration of all visible soft lens matter, was performed in all groups. The selected test agent was then injected into the lens capsule. Postoperative clinical examinations were performed at 1, 3, 7, 14, 30, 60, and 90 days. Posterior capsule opacification was quantified using high-resolution computer image analysis at 1, 2, and 3 months. Histological examination was performed at 3 months. Eyes treated with TMicro had significantly less PCO than the eyes in the BSS and TFree groups. While the BSS control eyes had increased PCO over 3 months, eyes in the TMicro group had reduced PCO over time in a dose-dependent fashion. Histological examination showed reduced lens epithelial cell proliferation in the TMicro groups, with no manifest damage to the cornea, iris, or retina compared with the BSS controls. There was a transient increase in postoperative inflammation in all tranilast-treated groups compared with the BSS controls. Sustained-release intracapsular tranilast reduced PCO in an experimental model of PCO, suggesting further investigation of its therapeutic potential is justified.Keywords
This publication has 22 references indexed in Scilit:
- Prevention of posterior capsule opacification by intraoperative single-dose pharmacologic agentsJournal of Cataract & Refractive Surgery, 2001
- Eradication of posterior capsule opacificationOphthalmology, 2001
- Organizations Supporting Developing-World Cataract Surgery and Present Surgical InitiativesSurvey of Ophthalmology, 2000
- Double-masked prospective ocular safety study of a lens epithelial cell antibody to prevent posterior capsule opacificationJournal of Cataract & Refractive Surgery, 2000
- Posterior capsule opacificationPart 1: Experimental investigationsJournal of Cataract & Refractive Surgery, 1999
- Inhibition of posterior capsule opacification with an immunotoxin specific for lens epithelial cells: 24 month clinical resultsJournal of Cataract & Refractive Surgery, 1998
- Evaluation of Visual Function Following Neodymium:YAG Laser Posterior CapsulotomyOphthalmology, 1997
- Inhibition of migrating lens epithelial cells by blocking the adhesion molecule integrin: A preliminary reportJournal of Cataract & Refractive Surgery, 1997
- Mitomycin against posterior capsular opacification: an experimental study in rabbits.British Journal of Ophthalmology, 1996
- Inhibition of migrating lens epithelial cells by sustained release of ethylenediaminetetraacetic acidJournal of Cataract & Refractive Surgery, 1996